Amber Horhey

Doctor of Medicine,  Toronto General - University Health Network 

Location: United States

Consulting Services

Legal Support Biostatistics Journal Manuscript Scientific Writing Pharma-CRO-Device

Areas Of Interest

Poisoning, Lead, Neurologic, Childhood v-abl Oncogene rap GTP-Binding Proteins Receptor, Interleukin 12 Yellow Nail Syndrome Specificity, Antibody Beclin 1 Ephrin-A5 Crimean-Congo Hemorrhagic Fever Computing Methodology DNA-Dependent DNA Polymerase I Organic Anion Transport Polypeptides Disodium, Sulfobromophthalein Characid Cerebral Hematomas, Traumatic Technetium Tc 99m Medronate Return-to-Work Picornaviruses Microscopic Angioscopies Concept, Astronomic Republic of South Africa Epazotes Therapeutic Occlusion P-type Adenosine Triphosphatases Vaccines, Recombinant DNA Cytalopram Azurin Blood Stain Enkephalin, 5-Methionine alpha Lymphotoxin MEK-ERK Pathways Systems, Medication Hospital

Professional Narrative

Dr. Amber Horhey was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Horhey has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.


Employment

Assistant Professor, Harvard Med 2000
Medical Writer, Harvard Med 2001

Education

Doctor of medicine, Baylor College 2008
Doctor of medicine, Harvard Medical School 2006

Referees


Publications

Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019 Mar;18(3):175-196. doi: 10.1038/s41573-018-0006-z. PMID: 30622344; PMCID: PMC6410566.

Reichmuth AM, Oberli MA, Jaklenec A, Langer R, Blankschtein D. mRNA vaccine delivery using lipid nanoparticles. Ther Deliv. 2016;7(5):319-34. doi: 10.4155/tde-2016-0006. Erratum in: Ther Deliv. 2016 Jun;7(6):411. PMID: 27075952; PMCID: PMC5439223.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Tang Z, Kong N, Zhang X, Liu Y, Hu P, Mou S, Liljeström P, Shi J, Tan W, Kim JS, Cao Y, Langer R, Leong KW, Farokhzad OC, Tao W. A materials-science perspective on tackling COVID-19. Nat Rev Mater. 2020;5(11):847-860. doi: 10.1038/s41578-020-00247-y. Epub 2020 Oct 14. PMID: 33078077; PMCID: PMC7556605.


Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :


Languages

Language Proficiency :

Translation Services :